Health
SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question – The Lancet
Since the onset of the COVID-19 pandemic, SARS-CoV-2 vaccine development has progressedat an unprecedented rate, with recent phase 3 trial data offering the tantalising…
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.
Copyright © 2021 Elsevier Inc. except certain content provided by third parties.
Privacy Policy Terms and Conditions
Continue Reading
-
Noosa News24 hours agoHow a 3D printed aorta helped surgeons replace a ‘ticking time bomb’ inside a man’s chest
-
Noosa News21 hours agoEnsure voices are heard – Proctor
-
Noosa News22 hours agoCity of Moreton Bay claims homeless people consented to having camps thrown away
-
General22 hours agoReserve Bank board still looking for yesterday’s news